Filter
5332
Filtered Results: 5332
Text search:
Tuberculosis
Featured
Recommendations
427
New Publications
1360
Language
Document type
No document type
3144
Studies & Reports
822
Guidelines
595
Manuals
231
Strategic & Response Plan
183
Fact sheets
99
Situation Updates
92
Training Material
86
Infographics
27
Resource Platforms
26
Brochures
11
Videos
7
Online Courses
6
Dashboards/Maps
2
App
1
Countries / Regions
India
243
Global
207
Western and Central Europe
138
Kenya
131
South Africa
121
Nepal
99
Latin America and the Carribbean
97
Uganda
93
Ethiopia
93
Tanzania
88
Nigeria
87
Malawi
87
Rwanda
80
Eastern Europe
75
Zambia
73
Liberia
73
Africa
72
Myanmar / Burma
68
Sierra Leone
65
Bangladesh
63
Namibia
63
Ghana
60
Ukraine
57
Colombia
55
Indonesia
55
Lesotho
53
Paraguay
48
Germany
46
Argentina
45
Peru
44
Cambodia
42
Venezuela
41
Asia
38
Mozambique
36
Senegal
34
Zimbabwe
33
Philippines
33
South–East Asia Region
33
Russia
33
Bolivia
27
Brazil
27
Congo, Democratic Republic of
24
Botswana
24
El Salvador
23
Burkina Faso
22
Haiti
22
South Sudan
19
Syria
18
East and Southern Africa
17
Tajikistan
16
Benin
13
Cameroon
13
Albania
13
West and Central Africa
13
Moldova
13
Chile
12
Eswatini/ Swaziland
12
Pakistan
12
Guinea
11
Eastern Europe and Central Asia
11
Georgia
11
Ecuador
11
Middle East and North Africa
10
Madagascar
10
Afghanistan
9
Yemen
9
Armenia
8
Papua New Guinea
8
Thailand
7
Vietnam
7
Sudan
7
Timor Leste/ East Timor
6
North America
6
Somalia
6
North Macedonia
5
Mexico
5
Togo
5
China
5
Uruguay
5
Nicaragua
5
Sri Lanka
5
Central African Republic
5
Angola
5
Iran
4
Laos
4
Estonia
4
Jordan
4
Saudi Arabia
4
Western Pacific Region
4
Jamaica
4
Lebanon
4
Romania
4
Honduras
4
Guatemala
4
USA
3
Dominican Republic
3
Guinea-Bissau
3
Hungary
3
Spain
3
Azerbaijan
3
Poland
3
Chad
3
Switzerland
2
Gambia
2
Morocco
2
Turkmenistan
2
Japan
2
Southern Africa
2
Palestine
2
Mali
2
Bhutan
2
Iraq
2
North Korea
1
Serbia
1
Turkey
1
Kazakhstan
1
Kyrgyzstan
1
Uzbekistan
1
Burundi
1
Mongolia
1
Qatar
1
Bulgaria
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
French Guyana
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Egypt
1
Slovakia
1
Greece
1
Libya
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2274
Clinical Guidelines
381
Public Health
245
Women & Child Health
182
Key Resources
147
Capacity Building
65
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
TB
1147
HIV
674
COVID-19
262
AMR
180
Mental Health
127
Health Financing Toolbox
120
NTDs
116
Caregiver
96
Pharmacy
89
Global Health Education
88
NCDs
84
Refugee
76
Conflict
73
Ebola & Marburg
72
Planetary Health
70
Malaria
60
Rapid Response
59
Disability
49
Polio
35
2.0 Rapid Response
34
Natural Hazards
30
Cholera
8
Zika
7
Social Ethics
5
Specific Hazards
3
South Sudan
1
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Tuberculosis Guideline for Adults
Guideline for Diagnosis...
For full publication see: https://drtbnetwork.org/mdr-tb-patient-education-flipchart
This tool can be used to educate new patients about TB and MDR-TB. The healthcare provider should review the material together with the patient. A treatment supporter can also use this flipchart at community lev...
This is a moment of reckoning in the fight against HIV, tuberculosis (TB) and malaria. For our Eighth Replenishment, the Global Fund needs US$18 billion to save 23 million lives, cut the death rate from the three diseases by 64% and help build a healthier, safer and more equitable world.
Estamos en un momento decisivo de la lucha contra el VIH, la tuberculosis y la malaria. El Fondo Mundial necesita recaudar 18.000 millones USD en la Octava Reposición de Recursos para salvar 23 millones de vidas, reducir en un 64% la tasa de mortalidad de las tres enfermedades, y ayudar a construir...
BMC Infectious Diseases volume 23, Article number: 342 (2023).
Tuberculosis (TB) is among the leading causes of death globally. The disease has a huge burden in Namibia, with a case notification rate of at least 442 per 100,000. To date, Namibia is among the countries with the highest global TB bur...
2023 was another year of significant progress in the fight against HIV, tuberculosis (TB) and malaria. In countries where the Global
Fund invests, there has been a full recovery from the disruptive impact of the COVID-19 pandemic. The results we have achieved in the last year build on our extraord...
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden of infections with bacteria resistant to antibiotics on the European population is comparable to that of influenza, tuberculosis and HIV/AIDS combined.
La técnica diagnóstica ampliamente usada a nivel mundial corresponde a la Prueba de Tuberculina o test de Mantoux, la que a través de la inyección de antígenos de Micobacterium tuberculosis permite medir la reacción del individuo y estimar su probabilidad de infección. El presente manual tie...
Buruli ulcer is a chronic, progressive skin disease caused by infection with Mycobacterium ulcerans. It is currently considered to be one of the neglected tropical diseases; less common than tuberculosis but more common than leprosy. The initial lesion is a painless subcutaneous nodule, usually less...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
This publication discusses official development assistance (ODA) provided by the USA with a focus on health, HIV/AIDS, tuberculosis and malaria. It also reflects upon ODA by the USA in comparison to other donors and funding targets.
The COVID-19 pandemic is rapidly spreading across the world and including countries affected by other infectious disease epidemics, such as HIV, tuberculosis (TB) and malaria. Over the past three decades, the global HIV response has gained experience in developing effective prevention approaches. Th...
Contains data from World Health Organization's data portal covering the following categories:
Mortality and global health estimates, Sustainable development goals, Millennium Development Goals (MDGs), Health systems, Malaria, Tuberculosis, Child health, Infectious diseases, Neglected Tropical Disea...
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
